Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses.

Yamamoto M, Onogi H, Kii I, Yoshida S, Iida K, Sakai H, Abe M, Tsubota T, Ito N, Hosoya T, Hagiwara M.

J Clin Invest. 2014 Aug;124(8):3479-88. doi: 10.1172/JCI73805. Epub 2014 Jul 8.

2.

Selective inhibition of HIV-1 replication by the CDK9 inhibitor FIT-039.

Okamoto M, Hidaka A, Toyama M, Hosoya T, Yamamoto M, Hagiwara M, Baba M.

Antiviral Res. 2015 Nov;123:1-4. doi: 10.1016/j.antiviral.2015.08.012. Epub 2015 Aug 21.

PMID:
26304705
3.

Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.

Terry BJ, Mazina KE, Tuomari AV, Haffey ML, Hagen M, Feldman A, Slusarchyk WA, Young MG, Zahler R, Field AK.

Antiviral Res. 1988 Dec 1;10(4-5):235-51.

PMID:
2852486
4.

Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.

Tanaka T, Okuyama-Dobashi K, Murakami S, Chen W, Okamoto T, Ueda K, Hosoya T, Matsuura Y, Ryo A, Tanaka Y, Hagiwara M, Moriishi K.

Antiviral Res. 2016 Sep;133:156-64. doi: 10.1016/j.antiviral.2016.08.008. Epub 2016 Aug 8.

PMID:
27515132
5.

Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication.

Tavis JE, Wang H, Tollefson AE, Ying B, Korom M, Cheng X, Cao F, Davis KL, Wold WS, Morrison LA.

Antimicrob Agents Chemother. 2014 Dec;58(12):7451-61. doi: 10.1128/AAC.03875-14. Epub 2014 Sep 29.

6.

A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.

Liang Y, Quenelle D, Vogel JL, Mascaro C, Ortega A, Kristie TM.

MBio. 2013 Feb 5;4(1):e00558-12. doi: 10.1128/mBio.00558-12.

7.

Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.

Hou J, Zhang Z, Huang Q, Yan J, Zhang X, Yu X, Tan G, Zheng C, Xu F, He S.

BMC Infect Dis. 2017 Mar 20;17(1):217. doi: 10.1186/s12879-017-2305-0.

8.

Efficacy of Cafon gel on cutaneous infection with herpes simplex virus (HSV)-2 and acyclovir-resistant HSV in mice.

Yoshida Y, Yamamura J, Sato H, Koyasu M, Obara Y, Sekiguchi H, Kawana T, Shiraki K.

J Dermatol Sci. 1996 Dec;13(3):237-41.

PMID:
9023706
9.

Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription.

Ou M, Sandri-Goldin RM.

PLoS One. 2013 Oct 18;8(10):e79007. doi: 10.1371/journal.pone.0079007. eCollection 2013.

10.
11.

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.

Chono K, Katsumata K, Kontani T, Kobayashi M, Sudo K, Yokota T, Konno K, Shimizu Y, Suzuki H.

J Antimicrob Chemother. 2010 Aug;65(8):1733-41. doi: 10.1093/jac/dkq198. Epub 2010 Jun 9.

PMID:
20534624
12.

Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.

Huang WY, Su YH, Yao HW, Ling P, Tung YY, Chen SH, Wang X, Chen SH.

J Gen Virol. 2010 Mar;91(Pt 3):591-8. doi: 10.1099/vir.0.016964-0. Epub 2009 Nov 11.

PMID:
19906941
13.
14.

Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.

Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura M, Shiraki K.

J Med Virol. 2004 Jan;72(1):112-20.

PMID:
14635018
15.

Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.

Schnitzler P, Schneider S, Stintzing FC, Carle R, Reichling J.

Phytomedicine. 2008 Dec;15(12):1108-16. doi: 10.1016/j.phymed.2008.06.009. Epub 2008 Aug 8.

PMID:
18691858
16.

Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.

Gong Y, Matthews B, Cheung D, Tam T, Gadawski I, Leung D, Holan G, Raff J, Sacks S.

Antiviral Res. 2002 Aug;55(2):319-29.

PMID:
12103432
17.

Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.

Schuhmacher A, Reichling J, Schnitzler P.

Phytomedicine. 2003;10(6-7):504-10.

PMID:
13678235
18.
19.

CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

Smith MC, Bayless AM, Goddard ET, Davido DJ.

Antiviral Res. 2011 Sep;91(3):259-66. doi: 10.1016/j.antiviral.2011.06.009. Epub 2011 Jun 22.

20.

Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.

Biswas S, Sukla S, Goldner T, Field HJ, Kropeit D, Paulsen D, Welbers A, Ruebsamen-Schaeff H, Zimmermann H, Birkmann A.

Antimicrob Agents Chemother. 2014 Jul;58(7):3843-52. doi: 10.1128/AAC.02641-14. Epub 2014 Apr 21.

Supplemental Content

Support Center